![Timothy Pigot](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Timothy Pigot
Corporate Officer/Principal bij
INHIBIKASE THERAPEUTICS, INC.
Profiel
Timothy J Pigot is Chief Commercial & Strategy Officer at Inhibikase Therapeutics, Inc. since 2025.
Formerly, Mr. Pigot was Chief Commercial Officer at Jade Biosciences, Inc. from 2021 to 2024.
Education includes undergraduate studies at State University of New York at Binghamton.
Actieve functies van Timothy Pigot
| Bedrijven | Functie | Begin |
|---|---|---|
| INHIBIKASE THERAPEUTICS, INC. | Corporate Officer/Principal | 19-08-2025 |
Eerdere bekende functies van Timothy Pigot
| Bedrijven | Functie | Einde |
|---|---|---|
| JADE BIOSCIENCES, INC. | Corporate Officer/Principal | 01-08-2024 |
| JADE BIOSCIENCES, INC. | Corporate Officer/Principal | - |
Opleiding van Timothy Pigot
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
19
Eerstegraads connecties
3
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 3 |
|---|---|
State University of New York at Binghamton
 State University of New York at Binghamton Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Inhibikase Therapeutics, Inc.
 Inhibikase Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes small-molecule kinase inhibitor therapeutics for neurological diseases | Health Technology |
Aerovate Therapeutics, Inc.
 Aerovate Therapeutics, Inc. BiotechnologyHealth Technology Provides gene therapy services | Health Technology |
